CN|EN
Recombinant Human VEGF-165
Recombinant Human VEGF-165
Item number:100-44
Product Features:
Contents Cat. No. Amount Storage Sell-by Date
Recombinant Human VEGF-165 100-44 10 µ g freeze-dried powder -20 ℃ to -80 ℃

12 months

Recombinant Human VEGF-165 100-44 100 µ g freeze-dried powder -20 ℃ to -80 ℃

12 months

Recombinant Human VEGF-165 100-44 500 µ g freeze-dried powder -20 ℃ to -80 ℃

12 months

Recombinant Human VEGF-165 100-44 1mg freeze-dried powder -20 ℃ to -80 ℃

12 months

 
  • Introduction
  • Citation
  • Sequence:

    MAPMAEGGGQ NHHEVVKFMD VYQRSYCHPI ETLVDIFQEY PDEIEYIFKP SCVPLMRCGG CCNDEGLECV PTEESNITMQ IMRIKPHQGQ HIGEMSFLQH NKCECRPKKD RARQENPCGP CSERRKHLFV QDPQTCKCSC KNTDSRCKAR QLELNERTCR CDKPRR

    Molecular weight:

    Dimer,19.3/38.6 kDa (166/332 aa)

    Recipe:

    Freeze dry from a 0.2 μ m filtered solution containing 0.1% trifluoroacetic acid (TFA)

    Protein purity:

    ≥ 95% determined by reduced and non reduced SDS-PAGE analysis

    Endotoxins:

    ≤ 0.1 EU/μg

    Biological activity:

    HUVEC proliferation ≤ 10 ng/mL

    English description:

    Vascular endothelial growth factor-A (VEGF-A) is produced by a wide variety of cell types, including tumor and vascular cells. The VEGF-165 isoform is a secreted protein that acts on receptors VEGFR-1 and VEGFR-2 to modulate endothelial cell proliferation and angiogenesis.


     


    Related Products